Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial

BMJ (Online)

Volumn 344, Issue 7852, 2012, Pages

  Morrison, Anthony P ^a,b   French, Paul ^b   Stewart, Suzanne L K ^a   Birchwood, Max ^c   Fowler, David ^d   Gumley, Andrew I ^e   Jones, Peter B ^f   Bentall, Richard P ^g   Lewis, Shôn W ^a   Murray, Graham K ^f   Patterson, Paul ^h   Brunet, Kat ^c   Conroy, Jennie ⁱ   Parker, Sophie ^b   Reilly, Tony ^j   Byrne, Rory ^b   Davies, Linda M ^a   Dunn, Graham ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

ⁱ CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^j NORFOLK AND SUFFOLK NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; HIGH RISK PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MENTAL HEALTH; MULTICENTER STUDY; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; COGNITIVE THERAPY; EARLY DIAGNOSIS; HUMANS; MENTAL DISORDERS; PSYCHOTIC DISORDERS; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859698552     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e2233     Document Type: Article

References (54)

1. Yung AR, McGorry PD, McFarlane C, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizoph Bull 1996;22:283-303. (Pubitemid 26174575)
2. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002;59:921-8.
3. Yung AR, Phillips LJ, Nelson B, Francey SM, PanYuen H, Simmons MB, et al. Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry 2011;72:430-40.
4. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006;163:790-9. (Pubitemid 44464525)
5. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizoph Res 2011;125:54-61.
6. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004;185:291-7. (Pubitemid 39331330)
7. Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, et al. 3 year follow-up of a randomised controlled trial of cognitive therapy for the prevention of psychosis in people at ultra-high risk. Schizoph Bull 2007;33:682-7. (Pubitemid 47343709)
8. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010;67:146-54.
9. Morrison AP, Bentall RP, French P, Walford L, Kilcommons A, Knight A, et al. A randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high risk individuals: study design and interim analysis of transition rate and psychological risk factors. Br J Psychiatry 2002;181(suppl 43):78-84.
10. Cognitive behaviour therapy for acute schizophrenia: a controlled trial. British Psychological Society Annual Conference; 1994; Brighton, UK.
11. Tarrier N, Yusupoff L, Kinner C, McCarthy E, Gladhill A, Haddock G, et al. A randomized controlled trial of intense cognitive behaviour therapy for chronic schizophrenia. BMJ 1998;317:303-7. (Pubitemid 28353823)
12. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, et al. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000;57:165-72. (Pubitemid 30075268)
13. Birchwood M. Early intervention in psychotic relapse: cognitive approaches to detection and management. In: Haddock G, Slade PD, eds. Cognitive-behavioural interventions with psychotic disorders. Routledge, 1996:171-211.
14. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994;164:759-69. (Pubitemid 24186895)
15. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Mapping the onset of psychosis - the Comprehensive Assessment of At Risk Mental States (CAARMS). Aust N Z J Psychiatry 2005;39:964-71. (Pubitemid 43904432)
16. Morrison AP. The interpretation of intrusions in psychosis: an integrative cognitive approach to hallucinations and delusions. Behav Cogn Psychother 2001;29:257-76. (Pubitemid 32666758)
17. French P, Morrison AP. Early detection and cognitive therapy for people at high risk of developing psychosis: a treatment approach. Wiley, 2004.
18. Blackburn IM, James I, Milne D, Baker CA, Standart S, Garland A, et al. The revised cognitive therapy scale (CTS-R): psychometric properties. Behav Cogn Psychother 2001;29:431-46. (Pubitemid 33622377)
19. Bell K, Startup M, French P, Morrison AP, Bucci SS, Fowler D. Therapist treatment adherence in CBT for people at ultra-high risk for psychosis: development of a new rating scale. Early Interv Psychiatry 2008;2:16.
20. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997;35:785-91. (Pubitemid 27336913)
21. Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther 1998;36:455-70. (Pubitemid 28256919)
22. Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry 1999;45:7-12. (Pubitemid 29158596)
23. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID): history, validation, and description. Arch Gen Psychiatry 1992;49:624-9.
24. Peters L. Discriminant validity of the Social Phobia and Anxiety Inventory (SPAI), the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). Behav Res Ther 2000;38:943-50. (Pubitemid 30336428)
25. Ainsworth JD, Harper RS. The PsyGrid experience: using web services in the study of schizophrenia. Int J Healthc Inf Syst Inform 2007;2:1-20.
26. Morrison AP, Stewart S, French P, Bentall RP, Birchwood M, Byrne RE, et al. Early Detection and Intervention Evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Interv Psychiatry 2011;5:24-32.
27. Everitt BS, Dunn G. Applied multivariate data analysis . Arnold, 1991.
28. Little RJA, Rubin DB. Statistical analysis with missing data . Wiley, 2002.
29. Hausman JA. Specification tests in econometrics. Econometrica 1978;46:1251-71.
30. Nagelkerke N, Fidler V, Bersen R, Borgdorff M. Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Stat Med 2000;19:1849-64. (Pubitemid 30448193)
31. Maracy M, Dunn G. Estimating dose-response effects in psychological treatment trials: the role of instrumental variables. Stat Methods Med Res 2011;20:191-215.
32. Yung AR, Yuen HP, Berger G, Francey S, Hung T-C, Nelson B, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007;33:673-81. (Pubitemid 47343718)
33. Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010;40:211-23.
34. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008;34:523-37.
35. Van Os J. Is there a continuum of psychotic experiences in the general population? Epidemiol Psichiatr Soc 2003;12:242-52. (Pubitemid 38029582)
36. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006;40:616-22. (Pubitemid 43984963)
37. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010;67:241-51.
38. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65:28-37.
39. Van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness?persistence?impairment model of psychotic disorder. Psychol Med 2009;39:179-95.
40. Loewy RL, Johnson JK, Cannon TD. Self-report of attenuated psychotic experiences in a college population. Schizophr Res 2007;93:144-51. (Pubitemid 46817933)
41. Morrison AP, Byrne RE, Bentall RP. DSM-5 and the 'psychosis risk syndrome': whose best interests. would it serve? Psychosis: Psychol, Soc Integr Approaches 2010;2:96-9.
42. Varghese D, Scott J, Welham J, Bor W, Najman J, O'Callaghan M, et al. Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults. Schizophr Bull 2011;37:389-93.
43. Van Rossum I, Dominguez MD, Lieb R, Wittchen HU, van Os J. Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull 2011;37:561-71.
44. Dominguez MD, Wichers M, Lieb R, Wittchen H-U, van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull 2011:37:84-93.
45. Foster C, Startup H, Potts L, Freeman D. A randomised controlled trial of a worry intervention for individuals with persistent persecutory delusions. J Behav Ther Exp Psychiatry 2010;41:45-51.
46. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 2011;168:800-5.
47. Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, et al. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr Res 2009;109:60-5.
48. International Early Psychosis Association. International clinical practice guidelines for early psychosis. Br J Psychiatry, 2005;(suppl)120-4.
49. Moncrieff J, Leo J. A systematic review of the effects of antipsychotic drugs on brain volume. Psychol Med 2010;40:1409-22.
50. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011;68:128-37.
51. Tost H, Braus DF, Hakimi S, Ruf M, Vollmert C, Hohn F, et al. Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat Neurosci 2010;13:920-2.
52. Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry 2011;68:609-16.
53. Alvarez-Jimenez M, Hetrick SE, Gonzalez-Blanch C, Gleeson JF, McGorry PD. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry 2008;193:101-7.
54. Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, et al. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res 2007;96:25-33. (Pubitemid 47494628)